Inside EMA: Data trust and the future of medicines
From clinical trials to real world evidence. How is data shaping the future of medicines? Discover how EMA uses data to guide safer, better decisions. In this episode of Inside EMA, we explore how different types of data are shaping the future of medicines regulation in Europe. EMA experts Peter Arlett and Denise Umuhire explain how real-world evidence - data from electronic healthcare records - complements clinical trials to support decisions on the safety and effectiveness of medicines. The episode also looks at DARWIN EU, the Agency’s network for generating evidence across Europe, and how data is used in a secure and transparent way to build trust.
▶︎
Inside EMA: From idea to medicines: how EMA supports innovation
▶︎
Inside EMA – Episode 1: The drugs don’t work: Addressing antimicrobial resistance
▶︎
European Shortages Monitoring Platform (ESMP) Training on Readable IDs and Updates
▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎
Getting Active: The Evolution of ETFs
▶︎
Q&A Clinic on S, O, R management services - April 2026
▶︎
Ukraine's drone war is isolating Crimea
▶︎
Broken Chains: Understanding Drug Shortages and Their Impact on Patients Webinar
▶︎
XEVMPD Q&A Clinic - May 2026
▶︎
‘Smart cities and digital twin technology: the case of Rotterdam’ data.europa academy
▶︎
Information Session on breakthrough medical devices
▶︎
Advancing equity in digital health: from principles to practice
▶︎
The Retail Exchange Episode 5: Transformation Within The South African Property Industry
▶︎
How do successful health programs move from research findings to real-world impact?
▶︎
BfArM and EMA: Data, AI and medicines regulation in Europe
▶︎
Eric Topol on the Future of Healthy Aging
▶︎
Emerging and developed market government bonds have "swapped places"
▶︎
Product Management Service (PMS) Q&A Clinic - March 2026
▶︎
Passing AAISM: A Deep Dive into Domain 1 AI Governance
▶︎